UNSPSC 51161722: Almitrine bismesylate

This classification denotes a cns stimulant with the molecular formula C26H29F2N7.2CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6RY6V6XM8T, chemically known as 6-4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-n,n'-di-2-propenyl-1,3,5-triazine-2,4-diamine dimethanesulfonate, but more generally known as almitrine bismesylate, which bears US NIH Compound Identifier 115048.

European Medicines Agency schedules almitrine bismesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05348MIG. Most nations, for tariff purposes, schedule almitrine bismesylate under HS 29336980. SMILES: CS(=O)(=O)O.CS(=O)(=O)O.C=CCNC1NC(NC(N1)N2CCN(CC2)C(C3CCC(CC3)F)C4CCC(CC4)F)NCC=C.

UNSPSC 51161722 Almitrine bismesylate is a Commodity code nominally describing a specific respiratory stimulant pharmaceutical, but the recent state and local opportunities tagged under it show a stark mismatch: the code captures emergency medical supplies and on-site pharmacy services that bear no relation to almitrine bismesylate's pharmaceutical profile. Seminole County, Florida solicited naloxone and drug deactivation systems through an IFB, while Hall County, Georgia issued an RFQ/P for comprehensive on-site pharmacy services at a county health clinic. Neither opportunity involves almitrine bismesylate as a product line. The code's tagging appears to reflect a cataloging error or an overly broad administrative classification rather than actual pharmaceutical procurement under this specific commodity description.

Recent activity originates in Florida and Georgia, with Seminole County's IFB60459723LAS (due July 26, 2023) targeting 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the county community health building, and Hall County's RFQ/P #47-010 (due June 4, 2026) seeking a single vendor to operate on-site pharmacy services for approximately 3,005 eligible employees, retirees, and dependents enrolled in the county's group health insurance plans. Neither solicitation is relevant to almitrine bismesylate procurement. State and local buyers using this code appear to be applying it to general pharmaceutical supply and pharmacy service categories rather than to this specific drug product, suggesting the code itself may not be actively used for its intended commodity scope in current state and local procurement activity.